Drug intelligence / Profile preview

Pantorush-D + Pantorush-DSR

Development stage
Phase 4
Lead developer
Acure Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Pantorush-D and Pantorush-DSR are fixed-dose combination products developed by Acure Pharma, containing the proton pump inhibitor (PPI) pantoprazole and the dopamine D2 receptor antagonist domperidone. Pantoprazole works by irreversibly inhibiting the gastric H+/K+ ATPase enzyme system (the proton pump) in parietal cells, thereby suppressing gastric acid secretion. Domperidone acts as a peripheral dopamine antagonist with prokinetic and antiemetic properties, enhancing gastrointestinal motility and reducing symptoms such as nausea and vomiting. This combination is primarily indicated for the treatment of gastroesophageal reflux disease (GERD), dyspepsia, and other acid-related disorders associated with upper gastrointestinal motility symptoms. Pantorush-DSR specifically utilizes a sustained-release formulation for the domperidone component to provide prolonged therapeutic effects.

Other names
pantoprazole + domperidone
02

Targets

DRD2 (Dopamine D2 Receptor)ATP4A (Potassium–transporting ATPase alpha chain 1)

Beyond the preview

Go deeper on Pantorush-D + Pantorush-DSR.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pantorush-D + Pantorush-DSR.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call